Featured Research

from universities, journals, and other organizations

Gene therapy stimulates protein that blocks immune attack and prevents type 1 diabetes in mice

Date:
July 7, 2011
Source:
Child & Family Research Institute
Summary:
Increasing a specific protein in areas of the pancreas that produce insulin blocks the immune attack that causes type 1 diabetes, researchers report.

Increasing a specific protein in areas of the pancreas that produce insulin blocks the immune attack that causes type 1 diabetes, researchers reported in the August issue of the Journal of Clinical Investigation, published early online.

Related Articles


The discovery could lead to a drug that prevents the progression of type 1 diabetes in people newly diagnosed who are in the "honeymoon" phase of the disease, when the immune system has not yet destroyed all of the insulin-producing beta cells in the pancreas.

The finding could also lead to new drugs for overcoming organ rejection in transplant patients and for improving the survival of transplanted islets -- the clusters of cells in the pancreas that contain beta cells.

Normally, as the immune system successfully defeats an infection, a special type of white blood cell called T-regulatory cells produce chemical signals that turn off the immune response.

The researchers took advantage of this phenomenon as they sought to protect the beta cells from immune attack.

They used a modified virus to insert the gene for a protein called CCL22 into the beta cells of a strain of mice known to develop diabetes. The gene caused the beta cells to produce the CCL22 protein. This attracted T-regulatory cells, which blocked the attacking immune cells and prevented most of the mice from developing type 1 diabetes.

CCL22 was discovered years ago by ovarian cancer researchers who noticed that tumours emit the protein to avoid being destroyed by the immune system.

"It's a novel way to turn down the immune system specifically in the region of the beta cells inside the pancreas, and that may be a big advantage over general immune suppression, which can have significant side effects," says Dr. Bruce Verchere, one of the study's principal investigators. He is head of the diabetes research program at the Child & Family Research Institute (CFRI) at BC Children's Hospital, Irving K Barber Chair in Diabetes Research, and professor, Department of Pathology & Laboratory Medicine and Department of Surgery at the University of British Columbia (UBC).

The study's co-lead author Dr. Joel Montane says more research is needed before the findings can be used clinically.

"Next, we need to better understand the mechanism," says Dr. Montane, a UBC post-doctoral fellow at CFRI. "We don't know exactly how CCL22 attracts T-regulatory cells to inhibit the immune response. Once we understand that, it may lead to a drug that can prevent or reverse diabetes."

"The research points to CCL22, or a modified form of it, as a potential drug to control the immune response," says Dr. Loraine Bischoff, the co-lead author. "Our strategy might also be used in other autoimmune disorders and in transplantation. The issue is how to administer it to humans. It's exciting because there are presently clinical trials using T-regulatory cells to prevent autoimmune disease."

A team of CFRI-UBC scientists, including co-principal investigator Dr. Rusung Tan, worked on this discovery.

This research was funded by the Canadian Institutes of Health Research, the Juvenile Diabetes Research Foundation, and the Michael Smith Foundation for Health Research.

The Diabetes Research Program at CFRI is supported by BC Children's Hospital Foundation and the Canucks for Kids Fund.


Story Source:

The above story is based on materials provided by Child & Family Research Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Joel Montane, Loraine Bischoff, Galina Soukhatcheva, Derek L. Dai, Gijs Hardenberg, Megan K. Levings, Paul C. Orban, Timothy J. Kieffer, Rusung Tan, C. Bruce Verchere. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. Journal of Clinical Investigation, 2011; DOI: 10.1172/JCI43048

Cite This Page:

Child & Family Research Institute. "Gene therapy stimulates protein that blocks immune attack and prevents type 1 diabetes in mice." ScienceDaily. ScienceDaily, 7 July 2011. <www.sciencedaily.com/releases/2011/07/110706093936.htm>.
Child & Family Research Institute. (2011, July 7). Gene therapy stimulates protein that blocks immune attack and prevents type 1 diabetes in mice. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2011/07/110706093936.htm
Child & Family Research Institute. "Gene therapy stimulates protein that blocks immune attack and prevents type 1 diabetes in mice." ScienceDaily. www.sciencedaily.com/releases/2011/07/110706093936.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins